COVID-19 can cause acute kidney injury and may cause or exacerbate chronic kidney
diseases, including glomerular diseases. SARS-CoV-2 infection of kidney cells has been …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and a relapsing-remitting course. New data regarding pathogenic …

Objective To explore long‐term safety and tolerability of anifrolumab 300 mg compared with
placebo in patients with systemic lupus erythematosus (SLE) who completed a Treatment of …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

Objective The risk of COVID‐19 infection is increased in patients with systemic lupus
erythematosus (SLE) versus those without SLE. Some immunosuppressive medications …

Treatment of systemic lupus erythematosus (SLE) currently employs agents with relatively
unselective immunosuppressive properties. However, two target-specific biological drugs …

Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …

Background Rheumatology researchers often categorize continuous predictor variables. We
aimed to show how this practice may alter results from observational studies in …

Objectives To investigate factors associated with severe COVID-19 in people with idiopathic
inflammatory myopathy (IIM). Methods Demographic data, clinical characteristics and COVID …

Pediatric systemic lupus erythematosus is a chronic autoimmune disorder with a highly
variable course and prognosis. It results in functional abnormalities in the immune system …